title: Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis.
authors.forename: Michael
authors.initials: M
authors.lastname: Karenfort
authors.forename: Bernd C
authors.initials: BC
authors.lastname: Kieseier
authors.forename: Daniel
authors.initials: D
authors.lastname: Tibussek
authors.forename: Birgit
authors.initials: B
authors.lastname: Assmann
authors.forename: Joerg
authors.initials: J
authors.lastname: Schaper
authors.forename: Ertan
authors.initials: E
authors.lastname: Mayatepek
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D002648:Child; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging / Q000379:methods; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab